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INTRODUCTION
Stroke is one of the most leading causes of mortality 
and disability in the world. (1) Many patients are left with 
residual cognitive deficits such as personality disorders, 
depression and memory loss after acute phase of 
stroke (2, 3). Post stroke dementia (PSD) is the second 
most common cause of dementia (4) and one of the 
main causes of dependency in survivors and includes 
any dementia after a stroke, irrespective of its cause (5). 
In Europe and North America, Alzheimer's disease 
predominates over PSD in a 2:1 ratio; in contrast, in 
some Asian countries PSD accounts for almost 50% of 
all dementias (6). Its prevalence ranges from 6 to 32% (7) 
and it has been found to be higher than previously 
expected, and a stroke increases the risk of dementia 4 
to 12 times (8). The diagnosis of PSD is based on the 
patient history, the clinical evaluation and neuroimaging 
(9), and it is   associated with high rates morbidity and 
mortality (2). Then, it is important to determine its risk 
factors. Some demographic, genetic and lesion-related 
radiological factors have been reported to predict 
dementia in stroke patients, but there has not been a 
consensus about them  (10, 11). Realizing the importance 
of research in this filed and lack of any published 
studies  about PSD from Iran , we decided to evaluate 
the prevalence of PSD  and some of  its putative  risk  
factors. To our knowledge, this is the first hospital-
based study among Iranian population about PSD.
METHODS 
1. Subjects 
This cross-sectional study was conducted on 151 
patients with first-ever stroke in Rafsanjan (south of 
Iran). Patients with a clinical suspicion of stroke under-
went neuroimaging (CT scan and MRI) and the diagnosis 
was confirmed by them. All patients with history of any 
underling disease especially dementia and mild cognitive 
impairment were excluded from the study except 
patients with ischemic heart disease (IHD), diabetes 
(DM), hypertension (HTN) and hyperlipidemia (HLP). 
Other exclusion criteria were history of opium or other 
substance addiction, inadequate vision and hearing, 
aphasia   any drug consumption (except drugs were 
used for treatment of IHD, DM, HTN, HLP) such as 
antipsychotic and anti depressant. The ethics committee 
of Yazd branch of Islamic Azad University had confirmed 
the research. 
2. Clinical characteristics
Following information was collected for each patient: 
baseline demographics (age, gender and educational 
status), stroke type according to Oxfordshire Community 
Stroke Project Classification. The subjects were 
screened for PSD using the DSM-IV at three months.
3. Statistical analysis
To analyze the data, descriptive statistics, and 
chi-square test were used and p≤0.05 was considered   
statistically significant.
RESULTS 
In our study, 71(47%) patients were male and the rest 
were80 (53%) female. Mean age of men and women 
were 65.5 and 66.5 years, respectively. 35 (23.2%)   
patients had PSD after three months. 70.6 % of 
patients were 60 years old or more. 88.7% of patients 
had ischemic infarction and the others had hemor-
rhagic stroke. The most frequent lesion locations were 
temporal, frontal and parietal lobes respectively. There 
was no significant statistical difference between PSD 
and sex, age, educational status, lesion location and 
kind of stroke. (Table 1)
Table1: Frequency of risk factors in patients 
CONCLUSION
In our hospital-based study prevalence of PSD was 
23.2 % . This finding shows that a significant portion of 
patients with stroke are prone to PSD. We did not find 
any published article about PSD concerning the Iranian 
population; it seems that in Iranian population, our 
study is the first in this field but many studies have been 
conducted in other countries. Prevalence of PSD is 
reported to be between 7% and 41%, (10). Some studies 
show the same frequency of PSD as our study, such as 
those conducted in Italy (24.6%) and America (26.3%) 
(12,13 ) where as others show lower prevalence such as 
Portugal( 5.9% ) and Taiwan( 9.2%) (14, 15) or higher in 
Finland (31.8%) (16). In a systematic review ,the prevalence 
of post stroke memory dysfunction varied from 23% to 
55% 3 months post stroke, which declined from 11% to 
31% 1 year post stroke.(17 ). The prevalence of dementia 
among people with a history of stroke is similar to that 
observed in subjects 10 years older without a history of 
stroke (18). Also, several studies have confirmed that 
stroke doubles the probability of developing dementia 
and that risk is higher in the first 6-12 months and in a 
community based study done over 25 years, the cumu-
lative incidence of PSD was 7% after 1 year, 10% after 
3 years, 15% after 5 years, 23% after 10 years, and 
48% after 25 years (19 ) These discrepancies may be   
related to different population studies, different criteria 
used for the diagnosis of dementia  and different time 
interval between stroke and the neuropsychological 
assessment (20). Although, stroke was recognized as an 
important cause of dementia more than a century ago 
(21), many aspects of PSD pathophysiology are not clear. 
The causes of PSD are multifactorial and involve 
neuronal networks needed for memory (22). Disturbance 
in some neurotransmitters (6), genetic factors (23), direct 
neuronal damage and impaired vascular autoregulatory 
mechanisms are some factors involved in PSD pato-
physiology. (2, 24, 25) Our results showed that PSD can be 
seen in both ischemic and hemorrhagic lesions. The 
risk and severity of cognitive disturbances occurring 
after a stroke do not seem to be influenced by type of   
stroke (ischemic or hemorrhagic) (8, 13, 14). In most 
studies such as ours, no gender specifity was observed 
(15,21). Similarly, many studies did not find any relation-
ship between location of the vascular lesion and PSD 
(14,15,21). Higher educational attainment has been found 
to be a protective factor for PSD (5) however, we could 
not ascertain this effect in our study and neither could 
the research performed in Spain (21). Although we did 
not find a relationship between age and dementia, 
some have studies suggested an association between 
the two (11, 21). It should be mentioned that  controversies 
about age, sex, location of lesion and educational 
status are frequent(7 ,11), and some factors such as  
dysphasia, hemiparesis, hemianopia (10), silent infarcts, 
cortical cerebral atrophy (26) medial temporal lobe atrophy 
and white matter changes , have been associated with 
an increased risk to develop PSD in some studies(19). 
Our study had some limitations. First, our study was a 
cross-sectional study. Second; we fallowed the patients 
only three months. Third, patients with aphasia were 
excluded from our study. These limitations may have 
some effects on the results. In conclusion, our study 
showed high prevalence of PSD in Iranian population. 
Both ischemic and hemorrhagic lesions have a similar 
effect on PSD and early recognition and treatment of 
PSD risk factors will definitely improve the quality of life 
of the patients.  
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INTRODUCTION
The “one and ahalf ” syndrome, first reported and 
named byMiller Fisher in 1967[1], is a clinical syndrome 
of horizontal gazepalsy to one side along with ipsilateral 
inter-nuclearopthalmoplegia (INO) resulting in loss of 
allhorizontal movements in the ipsilateral eye, except-
abduction of the contralateral eye. This syndrome is 
due to a unilateral lesion in the lower part of the dorsal 
pontinetegmentum, affecting the ipsilateralparamedi-
anpontine reticular formation (PPRF)which serves as 
the conjugate gaze center for horizontal eye movements, 
abducensnucleus and internuclear fibers of the ispsilateral 
medial longitudinal fasciculus (MLF). It is caused by 
circumscribed lesions of the pontinetegmentum as a 
result of infarction, hemorrhage, demyelination 
(Multiple Sclerosis), gliomas, and cystic lesions.It is one 
of the most localizing brainstem syndromes. Involvement 
of facial nervewith “one and a half” syndrome has been 
termed as “eight and a half” syndrome by Eggen-Berger 
[2] whofirst reported three such cases. Keeping this in 
view we report another rare case of “Eight and a half” 
syndromewith additional features of contralateral hemi-
paresis & hemihypoesthesia as a possible “NINE Syndrome”.
CASE PRESENTATION
A 50 year old female, right handed, known case of 
Hypertension and Diabetes mellitus admitted through 
casualty in Medical ward with sudden onset altered 
level of consciousness, left sided weakness, facial 
asymmetry, diplopia in horizontal gaze and two 
episodes of non projectile vomiting. At the time of 
presentation her blood pressure was 200/100mmHg, 
Pulse 90 b/min, respiratory rate 17 breaths/min and 
Tem.98F. On neurologic examination she had a Glasgow 
coma scale 11/15, Pupils 4mm and reactive bilaterally, 
fundoscopy normal, oculomotor examination revealed 
conjugated horizontal gaze paresis. Corneal reflex 
showed blink response on left side only, she had a right 
seventh nerve palsy which was lower motor neuron type 
and rest of cranial nerve were normal. On motor system 
examination bulk was normal, tone decreased on left 
side in upper and lower limb, power was 0/5 in upper 
limb and 3/5 in lower limb on left side while reflexes 
were 3+ and left planter was upgoing. The Respiratory 
system, cardiovascular and abdomen were all normal 
ABC was maintained & patient was started on i/v 3rd 
generation cephalosporin, tablet enalapril 10mg and 
regular insulin according to sliding scale while RBS 
done at presentation was 234mg/dl, meanwhile base-
line investigations sent. On second day of admission 
her blood pressure dropped to 160/90mmgh and GCS 
became 15/15. However oculomotor examination 
revealed conjugated horizontal gaze paresis except left 
sided nystagmus on abduction while from primary 
position vertical eye movements were normal, power 
was same. Cerebellar signs normal.  Pinprick, temperature, 
vibration &joint position sense were diminished on left 
side. Laboratory investigations showed a raised WBC 
count 13000/mm3 with platelet count of 373000, 
while blood urea, creatinine, HbsAg, Anti HCV, LFTs, 
electrolytes, APPT, PT-INR, Bleeding time and clotting 
time were normal. Urine detailed report showed pus 
cells. ECG was unremarkable and Hemoglobin A1c was 
7.3% (4.0-7.0%). Non contrast CT scan brain showed 
hyperdensesignal on right pontine tegmental region. 
Computed Tomographic Angiography did not reveal any 
aneurysm or vascular malformation, MRI brain plain 
done one week later revealed hyperintense signals over 
right pontinetegmentum on T1,T2 and flair imaging 
suggesting subacute hemorrhagic pontine infarction 
involvingcorticospinal tract and medial meniscus as 
well. MRA was unremarkable. Over a period of 1 week 
the condition of patient gradually improved in terms of 
power which became 1/5 in upper limb and 4/5 in lower 
limbbut her diplopia in horizontal gaze remained same. 
Patient was discharge on antihypertensive and oral 
hypoglycemic agents to follow up in Neurology OPD.
Figure -01 showing eye movement abnormality.
Figure-02 Non contrast CT scan showing hyperdense 
signal at right pontinetegmentum extending to 4th 
Ventricle&MRI Brain Plain showing Hyperintense signals 
on T1WI, T2WI and Flair imaging.
Figure-03 Magnetic Resonance Angiography (MRA) & 
CT Angiography Normal
DISCUSSION
One-and-a-half syndrome (OHS) refers to horizontal 
gaze palsy (one) with intranuclearopthalmoplegia (half) 
due to a lesion of the paramedianpontine reticular 
formation (PPRF) and medial longitudinal fasciculus. [1]. 
When one-and-a-half syndrome is associated with 
other cranial nerve involvement, the number of the 
cranial nerve is added to one-and-a-half to describe the 
clinical syndrome like eight and half syndrome [2,3,4], 
Nine syndrome [5], thirteen and half syndrome[6], 
Fifteen and half syndrome [7], sixteen and half syndrome 
[8,9]. Hence, “Eight-and-a-half” syndrome is “one-and-
a-half” syndrome (conjugated horizontal gaze palsy and 
internuclearopthalmoplegia) plus ipsilateral fascicular 
cranial nerve seventh palsy.Eight-and-a-half syndrome 
is caused by a lesion in the dorsal tegmentum of the 
caudal pons involving the PPRF or abducens nucleus 
and the medial longitudinal fasciculus (MLF), as well as 
the nucleus and fasciculus of the facial nerve [3]. The 
facial nucleus lies adjacent to the PPRF and gives rise 
to cranial nerve VII (CN7) which courses through the 
PPRF before circling the abducens nucleus and exiting 
the brainstem. This rare condition, particularly when 
isolated, is caused by circumscribed lesions of the 
pontinetegmentumas a result of infarction, hemor-
rhage, demyelination (Multiple Sclerosis), gliomas, and 
cystic lesions. Our case presented with eight and a half 
syndrome associated with contralateral hemiparesis 
and hemihypesthesia, Almost similar clinicalentity has 
been termed as “Nine syndrome” previously reported by 
Rosni at al [5] resulting from lacunar pontine infarction. 
Our patient was younger who developedhemorrhagic 
pontinetegmentum infarction as a result of high blood 
pressure. Pons is one of the most common sites for 
hemorrhagic stroke apart from putamen, thalamus and 
cerebellum.No such clinical entity has been reported 
yet in Pakistan.This is an addition in the spectrum of 
brainstem syndromes which not only have clinical 
importance but also help anatomic localization from 
student’s point of view as well in order to have appropri-
ate imaging.
CONCLUSION
Recognition of one-and-a-half plus syndrome at the 
bedside is of importance for precise localization and 
also for planning appropriate investigations to deter-
mine the possible cause.
REFERENCES
1.    Fisher CM. Some neuro-ophthalmological observa- 
      tions. J NeurolNeurosurg Psychiatry. 196 7;30:38 
      3-92.
2.   Eggenberger E. Eight-and-a-Half Syndrome: One- 
     and-a-Half Syndrome plus Cranial Nerve VII Palsy. 
     J Neuro-ophthalmology. 1998;18:114-116.
3.   SarwalA, Garewal M, Sahota S, Sivaraman M. 
      Eight-and-a-half syndrome. Journal of Neuroimaging. 
     July 2009;19(3):288-90.
4.   Nandhagopal R Krishnamoorthy SG. Eight‐and‐a‐half 
     syndrome. J NeurolNeurosurg Psychiatr y. April 
     2006;77(4): 463.
5.   Rosini F,  Pretegiani E, Guideri F, Cerase A, Rufa A, 
     Eight and a Half Syndrome with Hemiparesis and 
     Hemihypesthesia: The Nine Syndrome? J Stroke- 
     Cerebrovas Dis. November 2013;22(8):637–638.
6.   Rath A, Jawatkar J, Guruprasd H, Saxena A. B, 
      Murthy J. M. K.One-and-a-half Plus Syndromes: 
      Report of Three Cases .Annals of Indian Academy of 
      Neurology; 2007 Supplement 2, Vol. 10, p6
7.   Bae JS, Song HK.One-and-a-Half Syndrome with 
     Facial Diplegia: The 15 1/2 Syndrome?. Journal of 
     Neuro-opthmology. March 2005;25(1)55-53
8.   Cummins G, O’Hare A, Dunne R, et al. "Sixteen and 
      a half": a novel pontineneuroophthalmological syn- 
      drome. J Neurol. July 2011;258(7):1347-8.
9.   Singh et al / “Sixteen and a half”: a rare neurological
      syndrome. Internet Journal of Medical Update. July 
      2012;7(2):51-53
C A S E  R E P O R T
EIGHT -AND-HALF SYNDROME: A RARE NEURO-OPHTHALMIC
SYNDROME “POSSIBLE NINE SYNDROME”
Correspondence to: Dr. Muslim Ali Lakhiar, Assistant Professor Neurology. PUMHS Nawabshah-SBA. Email: drmuslimali@yahoo.com
Date of Submission: November 29, 2014, Date of Revision: December 28, 2014, Date of Acceptance: January 3, 2015
Dr. Muslim Ali Lakhiar, Dr. Shaheen Ahmed Mughal
ABSTRACT
“Eight-and-half” syndrome is “one-and-a-half” syndrome characterized by conjugated horizontal gaze palsy and inter-
nuclearopthalmoplegia plus ipsilateral fascicular seventh nerve palsy. We report a case of 50 year old woman who 
presented with right eight and half syndrome together with contralateral hemiparesis and hemihypesthesia. Non 
contrast CT scan brain showed hyperdensesignal on right pontine region. MRI brain plain revealed hemorrhagicpontine-
tegmentuminfarction as well as corticospinal tract and medial meniscus. This spectrum of presentation suggests a 
possible “Nine syndrome” as a novel neuropthalmicpontine syndrome. The first of its kind ever reported from Pakistan
Key words: infarction, hemorrhage, eight-and-halfSyndrome, nine syndrome.
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INTRODUCTION
Stroke is one of the most leading causes of mortality 
and disability in the world. (1) Many patients are left with 
residual cognitive deficits such as personality disorders, 
depression and memory loss after acute phase of 
stroke (2, 3). Post stroke dementia (PSD) is the second 
most common cause of dementia (4) and one of the 
main causes of dependency in survivors and includes 
any dementia after a stroke, irrespective of its cause (5). 
In Europe and North America, Alzheimer's disease 
predominates over PSD in a 2:1 ratio; in contrast, in 
some Asian countries PSD accounts for almost 50% of 
all dementias (6). Its prevalence ranges from 6 to 32% (7) 
and it has been found to be higher than previously 
expected, and a stroke increases the risk of dementia 4 
to 12 times (8). The diagnosis of PSD is based on the 
patient history, the clinical evaluation and neuroimaging 
(9), and it is   associated with high rates morbidity and 
mortality (2). Then, it is important to determine its risk 
factors. Some demographic, genetic and lesion-related 
radiological factors have been reported to predict 
dementia in stroke patients, but there has not been a 
consensus about them  (10, 11). Realizing the importance 
of research in this filed and lack of any published 
studies  about PSD from Iran , we decided to evaluate 
the prevalence of PSD  and some of  its putative  risk  
factors. To our knowledge, this is the first hospital-
based study among Iranian population about PSD.
METHODS 
1. Subjects 
This cross-sectional study was conducted on 151 
patients with first-ever stroke in Rafsanjan (south of 
Iran). Patients with a clinical suspicion of stroke under-
went neuroimaging (CT scan and MRI) and the diagnosis 
was confirmed by them. All patients with history of any 
underling disease especially dementia and mild cognitive 
impairment were excluded from the study except 
patients with ischemic heart disease (IHD), diabetes 
(DM), hypertension (HTN) and hyperlipidemia (HLP). 
Other exclusion criteria were history of opium or other 
substance addiction, inadequate vision and hearing, 
aphasia   any drug consumption (except drugs were 
used for treatment of IHD, DM, HTN, HLP) such as 
antipsychotic and anti depressant. The ethics committee 
of Yazd branch of Islamic Azad University had confirmed 
the research. 
2. Clinical characteristics
Following information was collected for each patient: 
baseline demographics (age, gender and educational 
status), stroke type according to Oxfordshire Community 
Stroke Project Classification. The subjects were 
screened for PSD using the DSM-IV at three months.
3. Statistical analysis
To analyze the data, descriptive statistics, and 
chi-square test were used and p≤0.05 was considered   
statistically significant.
RESULTS 
In our study, 71(47%) patients were male and the rest 
were80 (53%) female. Mean age of men and women 
were 65.5 and 66.5 years, respectively. 35 (23.2%)   
patients had PSD after three months. 70.6 % of 
patients were 60 years old or more. 88.7% of patients 
had ischemic infarction and the others had hemor-
rhagic stroke. The most frequent lesion locations were 
temporal, frontal and parietal lobes respectively. There 
was no significant statistical difference between PSD 
and sex, age, educational status, lesion location and 
kind of stroke. (Table 1)
Table1: Frequency of risk factors in patients 
CONCLUSION
In our hospital-based study prevalence of PSD was 
23.2 % . This finding shows that a significant portion of 
patients with stroke are prone to PSD. We did not find 
any published article about PSD concerning the Iranian 
population; it seems that in Iranian population, our 
study is the first in this field but many studies have been 
conducted in other countries. Prevalence of PSD is 
reported to be between 7% and 41%, (10). Some studies 
show the same frequency of PSD as our study, such as 
those conducted in Italy (24.6%) and America (26.3%) 
(12,13 ) where as others show lower prevalence such as 
Portugal( 5.9% ) and Taiwan( 9.2%) (14, 15) or higher in 
Finland (31.8%) (16). In a systematic review ,the prevalence 
of post stroke memory dysfunction varied from 23% to 
55% 3 months post stroke, which declined from 11% to 
31% 1 year post stroke.(17 ). The prevalence of dementia 
among people with a history of stroke is similar to that 
observed in subjects 10 years older without a history of 
stroke (18). Also, several studies have confirmed that 
stroke doubles the probability of developing dementia 
and that risk is higher in the first 6-12 months and in a 
community based study done over 25 years, the cumu-
lative incidence of PSD was 7% after 1 year, 10% after 
3 years, 15% after 5 years, 23% after 10 years, and 
48% after 25 years (19 ) These discrepancies may be   
related to different population studies, different criteria 
used for the diagnosis of dementia  and different time 
interval between stroke and the neuropsychological 
assessment (20). Although, stroke was recognized as an 
important cause of dementia more than a century ago 
(21), many aspects of PSD pathophysiology are not clear. 
The causes of PSD are multifactorial and involve 
neuronal networks needed for memory (22). Disturbance 
in some neurotransmitters (6), genetic factors (23), direct 
neuronal damage and impaired vascular autoregulatory 
mechanisms are some factors involved in PSD pato-
physiology. (2, 24, 25) Our results showed that PSD can be 
seen in both ischemic and hemorrhagic lesions. The 
risk and severity of cognitive disturbances occurring 
after a stroke do not seem to be influenced by type of   
stroke (ischemic or hemorrhagic) (8, 13, 14). In most 
studies such as ours, no gender specifity was observed 
(15,21). Similarly, many studies did not find any relation-
ship between location of the vascular lesion and PSD 
(14,15,21). Higher educational attainment has been found 
to be a protective factor for PSD (5) however, we could 
not ascertain this effect in our study and neither could 
the research performed in Spain (21). Although we did 
not find a relationship between age and dementia, 
some have studies suggested an association between 
the two (11, 21). It should be mentioned that  controversies 
about age, sex, location of lesion and educational 
status are frequent(7 ,11), and some factors such as  
dysphasia, hemiparesis, hemianopia (10), silent infarcts, 
cortical cerebral atrophy (26) medial temporal lobe atrophy 
and white matter changes , have been associated with 
an increased risk to develop PSD in some studies(19). 
Our study had some limitations. First, our study was a 
cross-sectional study. Second; we fallowed the patients 
only three months. Third, patients with aphasia were 
excluded from our study. These limitations may have 
some effects on the results. In conclusion, our study 
showed high prevalence of PSD in Iranian population. 
Both ischemic and hemorrhagic lesions have a similar 
effect on PSD and early recognition and treatment of 
PSD risk factors will definitely improve the quality of life 
of the patients.  
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INTRODUCTION
The “one and ahalf ” syndrome, first reported and 
named byMiller Fisher in 1967[1], is a clinical syndrome 
of horizontal gazepalsy to one side along with ipsilateral 
inter-nuclearopthalmoplegia (INO) resulting in loss of 
allhorizontal movements in the ipsilateral eye, except-
abduction of the contralateral eye. This syndrome is 
due to a unilateral lesion in the lower part of the dorsal 
pontinetegmentum, affecting the ipsilateralparamedi-
anpontine reticular formation (PPRF)which serves as 
the conjugate gaze center for horizontal eye movements, 
abducensnucleus and internuclear fibers of the ispsilateral 
medial longitudinal fasciculus (MLF). It is caused by 
circumscribed lesions of the pontinetegmentum as a 
result of infarction, hemorrhage, demyelination 
(Multiple Sclerosis), gliomas, and cystic lesions.It is one 
of the most localizing brainstem syndromes. Involvement 
of facial nervewith “one and a half” syndrome has been 
termed as “eight and a half” syndrome by Eggen-Berger 
[2] whofirst reported three such cases. Keeping this in 
view we report another rare case of “Eight and a half” 
syndromewith additional features of contralateral hemi-
paresis & hemihypoesthesia as a possible “NINE Syndrome”.
CASE PRESENTATION
A 50 year old female, right handed, known case of 
Hypertension and Diabetes mellitus admitted through 
casualty in Medical ward with sudden onset altered 
level of consciousness, left sided weakness, facial 
asymmetry, diplopia in horizontal gaze and two 
episodes of non projectile vomiting. At the time of 
presentation her blood pressure was 200/100mmHg, 
Pulse 90 b/min, respiratory rate 17 breaths/min and 
Tem.98F. On neurologic examination she had a Glasgow 
coma scale 11/15, Pupils 4mm and reactive bilaterally, 
fundoscopy normal, oculomotor examination revealed 
conjugated horizontal gaze paresis. Corneal reflex 
showed blink response on left side only, she had a right 
seventh nerve palsy which was lower motor neuron type 
and rest of cranial nerve were normal. On motor system 
examination bulk was normal, tone decreased on left 
side in upper and lower limb, power was 0/5 in upper 
limb and 3/5 in lower limb on left side while reflexes 
were 3+ and left planter was upgoing. The Respiratory 
system, cardiovascular and abdomen were all normal 
ABC was maintained & patient was started on i/v 3rd 
generation cephalosporin, tablet enalapril 10mg and 
regular insulin according to sliding scale while RBS 
done at presentation was 234mg/dl, meanwhile base-
line investigations sent. On second day of admission 
her blood pressure dropped to 160/90mmgh and GCS 
became 15/15. However oculomotor examination 
revealed conjugated horizontal gaze paresis except left 
sided nystagmus on abduction while from primary 
position vertical eye movements were normal, power 
was same. Cerebellar signs normal.  Pinprick, temperature, 
vibration &joint position sense were diminished on left 
side. Laboratory investigations showed a raised WBC 
count 13000/mm3 with platelet count of 373000, 
while blood urea, creatinine, HbsAg, Anti HCV, LFTs, 
electrolytes, APPT, PT-INR, Bleeding time and clotting 
time were normal. Urine detailed report showed pus 
cells. ECG was unremarkable and Hemoglobin A1c was 
7.3% (4.0-7.0%). Non contrast CT scan brain showed 
hyperdensesignal on right pontine tegmental region. 
Computed Tomographic Angiography did not reveal any 
aneurysm or vascular malformation, MRI brain plain 
done one week later revealed hyperintense signals over 
right pontinetegmentum on T1,T2 and flair imaging 
suggesting subacute hemorrhagic pontine infarction 
involvingcorticospinal tract and medial meniscus as 
well. MRA was unremarkable. Over a period of 1 week 
the condition of patient gradually improved in terms of 
power which became 1/5 in upper limb and 4/5 in lower 
limbbut her diplopia in horizontal gaze remained same. 
Patient was discharge on antihypertensive and oral 
hypoglycemic agents to follow up in Neurology OPD.
Figure -01 showing eye movement abnormality.
Figure-02 Non contrast CT scan showing hyperdense 
signal at right pontinetegmentum extending to 4th 
Ventricle&MRI Brain Plain showing Hyperintense signals 
on T1WI, T2WI and Flair imaging.
Figure-03 Magnetic Resonance Angiography (MRA) & 
CT Angiography Normal
DISCUSSION
One-and-a-half syndrome (OHS) refers to horizontal 
gaze palsy (one) with intranuclearopthalmoplegia (half) 
due to a lesion of the paramedianpontine reticular 
formation (PPRF) and medial longitudinal fasciculus. [1]. 
When one-and-a-half syndrome is associated with 
other cranial nerve involvement, the number of the 
cranial nerve is added to one-and-a-half to describe the 
clinical syndrome like eight and half syndrome [2,3,4], 
Nine syndrome [5], thirteen and half syndrome[6], 
Fifteen and half syndrome [7], sixteen and half syndrome 
[8,9]. Hence, “Eight-and-a-half” syndrome is “one-and-
a-half” syndrome (conjugated horizontal gaze palsy and 
internuclearopthalmoplegia) plus ipsilateral fascicular 
cranial nerve seventh palsy.Eight-and-a-half syndrome 
is caused by a lesion in the dorsal tegmentum of the 
caudal pons involving the PPRF or abducens nucleus 
and the medial longitudinal fasciculus (MLF), as well as 
the nucleus and fasciculus of the facial nerve [3]. The 
facial nucleus lies adjacent to the PPRF and gives rise 
to cranial nerve VII (CN7) which courses through the 
PPRF before circling the abducens nucleus and exiting 
the brainstem. This rare condition, particularly when 
isolated, is caused by circumscribed lesions of the 
pontinetegmentumas a result of infarction, hemor-
rhage, demyelination (Multiple Sclerosis), gliomas, and 
cystic lesions. Our case presented with eight and a half 
syndrome associated with contralateral hemiparesis 
and hemihypesthesia, Almost similar clinicalentity has 
been termed as “Nine syndrome” previously reported by 
Rosni at al [5] resulting from lacunar pontine infarction. 
Our patient was younger who developedhemorrhagic 
pontinetegmentum infarction as a result of high blood 
pressure. Pons is one of the most common sites for 
hemorrhagic stroke apart from putamen, thalamus and 
cerebellum.No such clinical entity has been reported 
yet in Pakistan.This is an addition in the spectrum of 
brainstem syndromes which not only have clinical 
importance but also help anatomic localization from 
student’s point of view as well in order to have appropri-
ate imaging.
CONCLUSION
Recognition of one-and-a-half plus syndrome at the 
bedside is of importance for precise localization and 
also for planning appropriate investigations to deter-
mine the possible cause.
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INTRODUCTION
Stroke is one of the most leading causes of mortality 
and disability in the world. (1) Many patients are left with 
residual cognitive deficits such as personality disorders, 
depression and memory loss after acute phase of 
stroke (2, 3). Post stroke dementia (PSD) is the second 
most common cause of dementia (4) and one of the 
main causes of dependency in survivors and includes 
any dementia after a stroke, irrespective of its cause (5). 
In Europe and North America, Alzheimer's disease 
predominates over PSD in a 2:1 ratio; in contrast, in 
some Asian countries PSD accounts for almost 50% of 
all dementias (6). Its prevalence ranges from 6 to 32% (7) 
and it has been found to be higher than previously 
expected, and a stroke increases the risk of dementia 4 
to 12 times (8). The diagnosis of PSD is based on the 
patient history, the clinical evaluation and neuroimaging 
(9), and it is   associated with high rates morbidity and 
mortality (2). Then, it is important to determine its risk 
factors. Some demographic, genetic and lesion-related 
radiological factors have been reported to predict 
dementia in stroke patients, but there has not been a 
consensus about them  (10, 11). Realizing the importance 
of research in this filed and lack of any published 
studies  about PSD from Iran , we decided to evaluate 
the prevalence of PSD  and some of  its putative  risk  
factors. To our knowledge, this is the first hospital-
based study among Iranian population about PSD.
METHODS 
1. Subjects 
This cross-sectional study was conducted on 151 
patients with first-ever stroke in Rafsanjan (south of 
Iran). Patients with a clinical suspicion of stroke under-
went neuroimaging (CT scan and MRI) and the diagnosis 
was confirmed by them. All patients with history of any 
underling disease especially dementia and mild cognitive 
impairment were excluded from the study except 
patients with ischemic heart disease (IHD), diabetes 
(DM), hypertension (HTN) and hyperlipidemia (HLP). 
Other exclusion criteria were history of opium or other 
substance addiction, inadequate vision and hearing, 
aphasia   any drug consumption (except drugs were 
used for treatment of IHD, DM, HTN, HLP) such as 
antipsychotic and anti depressant. The ethics committee 
of Yazd branch of Islamic Azad University had confirmed 
the research. 
2. Clinical characteristics
Following information was collected for each patient: 
baseline demographics (age, gender and educational 
status), stroke type according to Oxfordshire Community 
Stroke Project Classification. The subjects were 
screened for PSD using the DSM-IV at three months.
3. Statistical analysis
To analyze the data, descriptive statistics, and 
chi-square test were used and p≤0.05 was considered   
statistically significant.
RESULTS 
In our study, 71(47%) patients were male and the rest 
were80 (53%) female. Mean age of men and women 
were 65.5 and 66.5 years, respectively. 35 (23.2%)   
patients had PSD after three months. 70.6 % of 
patients were 60 years old or more. 88.7% of patients 
had ischemic infarction and the others had hemor-
rhagic stroke. The most frequent lesion locations were 
temporal, frontal and parietal lobes respectively. There 
was no significant statistical difference between PSD 
and sex, age, educational status, lesion location and 
kind of stroke. (Table 1)
Table1: Frequency of risk factors in patients 
CONCLUSION
In our hospital-based study prevalence of PSD was 
23.2 % . This finding shows that a significant portion of 
patients with stroke are prone to PSD. We did not find 
any published article about PSD concerning the Iranian 
population; it seems that in Iranian population, our 
study is the first in this field but many studies have been 
conducted in other countries. Prevalence of PSD is 
reported to be between 7% and 41%, (10). Some studies 
show the same frequency of PSD as our study, such as 
those conducted in Italy (24.6%) and America (26.3%) 
(12,13 ) where as others show lower prevalence such as 
Portugal( 5.9% ) and Taiwan( 9.2%) (14, 15) or higher in 
Finland (31.8%) (16). In a systematic review ,the prevalence 
of post stroke memory dysfunction varied from 23% to 
55% 3 months post stroke, which declined from 11% to 
31% 1 year post stroke.(17 ). The prevalence of dementia 
among people with a history of stroke is similar to that 
observed in subjects 10 years older without a history of 
stroke (18). Also, several studies have confirmed that 
stroke doubles the probability of developing dementia 
and that risk is higher in the first 6-12 months and in a 
community based study done over 25 years, the cumu-
lative incidence of PSD was 7% after 1 year, 10% after 
3 years, 15% after 5 years, 23% after 10 years, and 
48% after 25 years (19 ) These discrepancies may be   
related to different population studies, different criteria 
used for the diagnosis of dementia  and different time 
interval between stroke and the neuropsychological 
assessment (20). Although, stroke was recognized as an 
important cause of dementia more than a century ago 
(21), many aspects of PSD pathophysiology are not clear. 
The causes of PSD are multifactorial and involve 
neuronal networks needed for memory (22). Disturbance 
in some neurotransmitters (6), genetic factors (23), direct 
neuronal damage and impaired vascular autoregulatory 
mechanisms are some factors involved in PSD pato-
physiology. (2, 24, 25) Our results showed that PSD can be 
seen in both ischemic and hemorrhagic lesions. The 
risk and severity of cognitive disturbances occurring 
after a stroke do not seem to be influenced by type of   
stroke (ischemic or hemorrhagic) (8, 13, 14). In most 
studies such as ours, no gender specifity was observed 
(15,21). Similarly, many studies did not find any relation-
ship between location of the vascular lesion and PSD 
(14,15,21). Higher educational attainment has been found 
to be a protective factor for PSD (5) however, we could 
not ascertain this effect in our study and neither could 
the research performed in Spain (21). Although we did 
not find a relationship between age and dementia, 
some have studies suggested an association between 
the two (11, 21). It should be mentioned that  controversies 
about age, sex, location of lesion and educational 
status are frequent(7 ,11), and some factors such as  
dysphasia, hemiparesis, hemianopia (10), silent infarcts, 
cortical cerebral atrophy (26) medial temporal lobe atrophy 
and white matter changes , have been associated with 
an increased risk to develop PSD in some studies(19). 
Our study had some limitations. First, our study was a 
cross-sectional study. Second; we fallowed the patients 
only three months. Third, patients with aphasia were 
excluded from our study. These limitations may have 
some effects on the results. In conclusion, our study 
showed high prevalence of PSD in Iranian population. 
Both ischemic and hemorrhagic lesions have a similar 
effect on PSD and early recognition and treatment of 
PSD risk factors will definitely improve the quality of life 
of the patients.  
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INTRODUCTION
The “one and ahalf ” syndrome, first reported and 
named byMiller Fisher in 1967[1], is a clinical syndrome 
of horizontal gazepalsy to one side along with ipsilateral 
inter-nuclearopthalmoplegia (INO) resulting in loss of 
allhorizontal movements in the ipsilateral eye, except-
abduction of the contralateral eye. This syndrome is 
due to a unilateral lesion in the lower part of the dorsal 
pontinetegmentum, affecting the ipsilateralparamedi-
anpontine reticular formation (PPRF)which serves as 
the conjugate gaze center for horizontal eye movements, 
abducensnucleus and internuclear fibers of the ispsilateral 
medial longitudinal fasciculus (MLF). It is caused by 
circumscribed lesions of the pontinetegmentum as a 
result of infarction, hemorrhage, demyelination 
(Multiple Sclerosis), gliomas, and cystic lesions.It is one 
of the most localizing brainstem syndromes. Involvement 
of facial nervewith “one and a half” syndrome has been 
termed as “eight and a half” syndrome by Eggen-Berger 
[2] whofirst reported three such cases. Keeping this in 
view we report another rare case of “Eight and a half” 
syndromewith additional features of contralateral hemi-
paresis & hemihypoesthesia as a possible “NINE Syndrome”.
CASE PRESENTATION
A 50 year old female, right handed, known case of 
Hypertension and Diabetes mellitus admitted through 
casualty in Medical ward with sudden onset altered 
level of consciousness, left sided weakness, facial 
asymmetry, diplopia in horizontal gaze and two 
episodes of non projectile vomiting. At the time of 
presentation her blood pressure was 200/100mmHg, 
Pulse 90 b/min, respiratory rate 17 breaths/min and 
Tem.98F. On neurologic examination she had a Glasgow 
coma scale 11/15, Pupils 4mm and reactive bilaterally, 
fundoscopy normal, oculomotor examination revealed 
conjugated horizontal gaze paresis. Corneal reflex 
showed blink response on left side only, she had a right 
seventh nerve palsy which was lower motor neuron type 
and rest of cranial nerve were normal. On motor system 
examination bulk was normal, tone decreased on left 
side in upper and lower limb, power was 0/5 in upper 
limb and 3/5 in lower limb on left side while reflexes 
were 3+ and left planter was upgoing. The Respiratory 
system, cardiovascular and abdomen were all normal 
ABC was maintained & patient was started on i/v 3rd 
generation cephalosporin, tablet enalapril 10mg and 
regular insulin according to sliding scale while RBS 
done at presentation was 234mg/dl, meanwhile base-
line investigations sent. On second day of admission 
her blood pressure dropped to 160/90mmgh and GCS 
became 15/15. However oculomotor examination 
revealed conjugated horizontal gaze paresis except left 
sided nystagmus on abduction while from primary 
position vertical eye movements were normal, power 
was same. Cerebellar signs normal.  Pinprick, temperature, 
vibration &joint position sense were diminished on left 
side. Laboratory investigations showed a raised WBC 
count 13000/mm3 with platelet count of 373000, 
while blood urea, creatinine, HbsAg, Anti HCV, LFTs, 
electrolytes, APPT, PT-INR, Bleeding time and clotting 
time were normal. Urine detailed report showed pus 
cells. ECG was unremarkable and Hemoglobin A1c was 
7.3% (4.0-7.0%). Non contrast CT scan brain showed 
hyperdensesignal on right pontine tegmental region. 
Computed Tomographic Angiography did not reveal any 
aneurysm or vascular malformation, MRI brain plain 
done one week later revealed hyperintense signals over 
right pontinetegmentum on T1,T2 and flair imaging 
suggesting subacute hemorrhagic pontine infarction 
involvingcorticospinal tract and medial meniscus as 
well. MRA was unremarkable. Over a period of 1 week 
the condition of patient gradually improved in terms of 
power which became 1/5 in upper limb and 4/5 in lower 
limbbut her diplopia in horizontal gaze remained same. 
Patient was discharge on antihypertensive and oral 
hypoglycemic agents to follow up in Neurology OPD.
Figure -01 showing eye movement abnormality.
Figure-02 Non contrast CT scan showing hyperdense 
signal at right pontinetegmentum extending to 4th 
Ventricle&MRI Brain Plain showing Hyperintense signals 
on T1WI, T2WI and Flair imaging.
Figure-03 Magnetic Resonance Angiography (MRA) & 
CT Angiography Normal
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DISCUSSION
One-and-a-half syndrome (OHS) refers to horizontal 
gaze palsy (one) with intranuclearopthalmoplegia (half) 
due to a lesion of the paramedianpontine reticular 
formation (PPRF) and medial longitudinal fasciculus. [1]. 
When one-and-a-half syndrome is associated with 
other cranial nerve involvement, the number of the 
cranial nerve is added to one-and-a-half to describe the 
clinical syndrome like eight and half syndrome [2,3,4], 
Nine syndrome [5], thirteen and half syndrome[6], 
Fifteen and half syndrome [7], sixteen and half syndrome 
[8,9]. Hence, “Eight-and-a-half” syndrome is “one-and-
a-half” syndrome (conjugated horizontal gaze palsy and 
internuclearopthalmoplegia) plus ipsilateral fascicular 
cranial nerve seventh palsy.Eight-and-a-half syndrome 
is caused by a lesion in the dorsal tegmentum of the 
caudal pons involving the PPRF or abducens nucleus 
and the medial longitudinal fasciculus (MLF), as well as 
the nucleus and fasciculus of the facial nerve [3]. The 
facial nucleus lies adjacent to the PPRF and gives rise 
to cranial nerve VII (CN7) which courses through the 
PPRF before circling the abducens nucleus and exiting 
the brainstem. This rare condition, particularly when 
isolated, is caused by circumscribed lesions of the 
pontinetegmentumas a result of infarction, hemor-
rhage, demyelination (Multiple Sclerosis), gliomas, and 
cystic lesions. Our case presented with eight and a half 
syndrome associated with contralateral hemiparesis 
and hemihypesthesia, Almost similar clinicalentity has 
been termed as “Nine syndrome” previously reported by 
Rosni at al [5] resulting from lacunar pontine infarction. 
Our patient was younger who developedhemorrhagic 
pontinetegmentum infarction as a result of high blood 
pressure. Pons is one of the most common sites for 
hemorrhagic stroke apart from putamen, thalamus and 
cerebellum.No such clinical entity has been reported 
yet in Pakistan.This is an addition in the spectrum of 
brainstem syndromes which not only have clinical 
importance but also help anatomic localization from 
student’s point of view as well in order to have appropri-
ate imaging.
CONCLUSION
Recognition of one-and-a-half plus syndrome at the 
bedside is of importance for precise localization and 
also for planning appropriate investigations to deter-
mine the possible cause.
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